Champions Oncology (CSBR) Shareholder's Equity Growth (5y) (2016 - 2026)
Champions Oncology (CSBR) Shareholder's Equity Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Champions Oncology |
78.46 Mn |
71.46 Mn |
13.89 Mn |
| Date | Value |
|---|
| Jan 31, 2026 |
-11.94% |
| Oct 31, 2025 |
-9.30% |
| Jul 31, 2025 |
-8.49% |
| Apr 30, 2025 |
-5.85% |
| Jan 31, 2025 |
-0.16% |
| Oct 31, 2024 |
-20.27% |
| Jul 31, 2024 |
-17.00% |
| Apr 30, 2024 |
-23.65% |
| Jan 31, 2024 |
-23.61% |
| Oct 31, 2023 |
-45.82% |
| Jul 31, 2023 |
25.84% |
| Apr 30, 2023 |
334.31% |
| Jan 31, 2023 |
71.80% |
| Oct 31, 2022 |
89.74% |
| Jul 31, 2022 |
98.70% |
| Apr 30, 2022 |
86.79% |
| Jan 31, 2022 |
35.26% |
| Oct 31, 2021 |
20.29% |
| Jul 31, 2021 |
18.87% |
| Apr 30, 2021 |
99.00% |
